Skip to content
HOME > About Company > Subsidiary

사업회사소개

SK플라즈마
SK플라즈마
  • A new challenge for SK plasma to take a leap forward begins.
  • SK plasma's plasma fractionation business started in 1970 and is being conducted under the mission of SK discovery to 'promote human health and protect the earth's environment'.

    In 2015, SK chemicals Life Science biz. was divided and established as a new corporation as we focused on our core competencies in the blood product business to enhance our competitiveness and accelerate global advancement.

    Blood products are essential medicines to treat diseases that can be directly related to human life, such as congenital immunodeficiency diseases and hemophilia. Accordingly, SK plasma not only creates economic value, but also creates social value while performing the role of the national health and safety net.

    To respond to the rapidly increasing domestic and overseas demand for blood products, SK plasma completed a new, state-of-the-art blood product fractionation plant in Andong, Gyeongsangbuk-do in 2016.
    In August 2018, it received KGMP approval and started commercial production. In addition, we are taking the lead in strengthening our competitiveness and improving human health through continuous development of new products.


    Address : 310 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea
    Tel : 82-80-969-9967
    Homepage : https://www.skplasma.com Go